RESPOND CRT

RESPOND CRT
205731091813

Number of Participants

1032

Eligibility

Patients with heart failure that meet current indication for cardiac resynchronization therapy.

Purpose

The purpose of this study is to test both the good and bad effects of using an investigational right atrium lead and CRT-D device during cardiac resynchronization therapy. The right atrium lead has a sensor that will automatically calculate the best time to pace the heart. The study will compare the responses to CRT-D therapy in patients receiving the automatic optimization in the device or by an echocardiogram.

Treatment

All participants will receive an investigational right ventricular lead and device along with two approved leads. After implant, participants will be randomly assigned to have the device optimized automatically or by echocardiography. All participants will have routine device follow-up.

Principal Investigator

Peter Santucci

M.D., FACC, FAHA
Cardiology
Associate Professor

Enrollment

(708) 216-2644

More Clinical Trials

See Also

© 2011 Loyola University Chicago Health Sciences Division. All rights reserved.  &npsp; Privacy Policy   Privacy Policy